John R. Kline - 06 Dec 2023 Form 4 Insider Report for CNO Financial Group, Inc. (CNO)

Reporting relationship: SVP and CAO
Issuer ticker: CNO
Reported as of: 06 Dec 2023
Net transaction value: -$155,853
SEC form: 4
Accepted by SEC: 07 Dec 2023, 16:20:58 UTC
Prior SEC filing: 30 Nov 2023
Next SEC filing: 26 Nov 2024
Source filing: View source filing
Reporting owner signature: Rachel J. Spehler, Attorney-in-Fact

Key filing fact

John R. Kline filed Form 4 for CNO Financial Group, Inc. (CNO) on 07 Dec 2023.

Key facts

This page summarizes John R. Kline's Form 4 filing for CNO Financial Group, Inc. (CNO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Dec 2023, 16:20.

Change

Previous filing in this sequence was filed on 30 Nov 2023.
Current net transaction value: -$155,853.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNO transaction

Common Stock

Sale

Transaction value: $155,853
Shares: -5,757
Change %: -8.2%
Price: $27.07
Shares after: 64,730
Date: 06 Dec 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Shares sold pursuant to a 10b5-1 trading plan adopted on August 17, 2023.

Footnote F2

Reflects weighted average sale price. Sales ranged from $26.87 to $27.20 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.